Physician profile
Carson E Scheidler
NPI 1114722402
$779.28
in general payments reported to CMS, 2019-2025
13 companies · $779 in 2025
The $779 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.28 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $192.60 | 2025 | Airsupra, Farxiga |
| Astellas Pharma US INC | $148.76 | 2025 | Veozah |
| Abbvie INC. | $140.95 | 2025 | |
| Glaxosmithkline, LLC. | $61.89 | 2025 | Trelegy Ellipta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $50.97 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $33.01 | 2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.32 | 2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $25.93 | 2025 | |
| Exact Sciences Corporation | $25.22 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $22.80 | 2025 | Spravato |
| Bayer Healthcare Pharmaceuticals INC. | $18.59 | 2025 | |
| Renalytix Ai, INC. | $15.70 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Novo Nordisk INC | $14.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Scheidler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.